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Categorical descriptors, N (%)
Study site (Oregon) 361 ( 44 )
Sex (Female) 700 ( 86 )
Race (White) 650 ( 80 )
Ethnicity (Hispanic) 85 ( 10 )
Child (age <13) at home 248 ( 30 )
Physician 52 ( 6 )
Work in Hospital 440 ( 54 )
Work in Emergency Dept. 155 ( 19 )
Chronic medical condition b 151 ( 19 )
Continuous descriptors, Median (SD)
Age (years) 48 ( 12 )
Household size (0-7) 2 ( 2 )
Education (5-levels) 16 ( 2 )
Self-rated health status (5-levels) 4 ( 1 )
Body mass index (kg/m2) 28 ( 28 )
Direct patient care per week (hours) 34 ( 1 )
Prior vaccinations, N (%)
2006-07 IIV3 433 ( 53 )
2007-08 IIV3 391 ( 48 )
2008-09 IIV3 464 ( 57 )
2009-10 IIV3 589 ( 72 )
2009 MIV A(H1N1)pdm09 401 ( 49 )
2010-11 IIV3 607 ( 74 )
Sum of Prior IIV3, Mean (SD) 3 ( 1 )
Table 1. Characteristics of 816 Participants in a Healthcare Personnel Cohort 
with Vaccination Records through Four Prior Years
b Presence of a chronic medical condition was identified by a medical visit during the 
prior year in the electronic medical record for a medical condition associated with 
increased risk of influenza  complications (codes available from the authors).
* p < .05; ** p < .01; *** p < .001
Sample a
a Sample (N = 816) includes health care personnel with medical and vaccination 
records since July, 2006 and excludes those who received live attenuated influenza 
vaccine (LAIV) in 2010-11 and/or in any season since 2006-07.
Subgroup Sum of IIV3 
2006-07 to 
2009-10 N
2010-11 
Vaccinated
4 IIV3s 227 10 ( 9 - 11 ) 14 ( 9 - 18 ) 3 ( 1 - 10 ) 23 ( 20 - 27 ) 2.3 ( 2.1 - 2.6 ) 46 ( 40 - 51 ) 11 ( 6 - 15 ) 14 ( 12 - 16 ) 0.6 ( 0.6 - 0.7 ) 23 ( 17 - 29 ) 5 ( 2 - 8 )
3 IIV3s 153 12 ( 11 - 14 ) 19 ( 13 - 25 ) 2 ( 0 - 13 ) 32 ( 28 - 38 ) 2.6 ( 2.3 - 3.0 ) 55 ( 48 - 61 ) 8 ( 3 - 13 ) 17 ( 15 - 20 ) 0.5 ( 0.5 - 0.6 ) 32 ( 25 - 39 ) 2 ( 0 - 6 )
2 IIV3s 85 10 ( 8 - 12 ) 17 ( 9 - 25 ) 3 ( 0 - 7 ) 33 ( 25 - 44 ) 3.4 ( 2.8 - 4.3 ) 56 ( 47 - 65 ) 20 ( 13 - 26 ) 16 ( 13 - 21 ) 0.5 ( 0.4 - 0.6 ) 34 ( 24 - 43 ) 11 ( 5 - 16 )
1 IIV3s 86 13 ( 10 - 17 ) 26 ( 18 - 33 ) 9 ( 1 - 4 ) 57 ( 42 - 76 ) 4.3 ( 3.3 - 5.5 ) 63 ( 54 - 72 ) 32 ( 26 - 39 ) 26 ( 20 - 32 ) 0.5 ( 0.4 - 0.6 ) 40 ( 31 - 50 ) 19 ( 14 - 24 )
0 IIV3s 27 8 ( 6 - 11 ) 12 ( 0 - 25 ) 4 ( 0 - 6 ) 50 ( 29 - 88 ) 6.2 ( 3.4 - 11.3 ) 69 ( 54 - 85 ) 37 ( 26 - 48 ) 15 ( 11 - 23 ) 0.4 ( 0.2 - 0.5 ) 25 ( 9 - 41 ) 4 ( 0 - 14 )
2010-11 
Unvaccinated
4 IIV3s 7 15 ( 8 - 28 ) 26 ( 3 - 50 ) 1 ( 0 - 15 ) 16 ( 8 - 32 ) 0.9 ( 0.9 - 0.9 ) 15 ( 11 - 42 ) 1 ( 0 - 15 )
3 IIV3s 15 12 ( 8 - 19 ) 13 ( 0 - 29 ) 7 ( 0 - 16 ) 15 ( 10 - 25 ) 0.8 ( 0.9 - 1.9 ) 18 ( 1 - 36 ) 1 ( 0 - 8 )
2 IIV3s 33 12 ( 9 - 16 ) 18 ( 7 - 29 ) 6 ( 0 - 12 ) 13 ( 10 - 19 ) 0.9 ( 0.9 - 1.3 ) 25 ( 13 - 37 ) 3 ( 0 - 9 )
1 IIV3s 44 11 ( 8 - 14 ) 18 ( 8 - 27 ) 7 ( 0 - 12 ) 10 ( 8 - 14 ) 1.1 ( 0.9 - 1.4 ) 14 ( 3 - 25 ) 7 ( 1 - 12 )
0 IIV3s 110 7 ( 6 - 7 ) 7 ( 1 - 13 ) 1 ( 0 - 6 ) 8 ( 7 - 9 ) 1.2 ( 1.6 - 1.3 ) 11 ( 5 - 18 ) 3 ( 0 - 7 )
Table 2.  Serum Hemagglutination Inhibition Antibody (HI) Titers for A/Perth/16/2009 (H3N2) at Preseason, Post-Vaccination, and Post-Season by Number of Inactivated Influenza Vaccinations (IIV3s) during the Prior 
Four Seasons, including Estimated Geometric Mean Titer (GMT), Elevated Titers of ≥40 and >100, and Geometric Mean Fold Change Ratios (GMRs), among Healthcare Personnel Vaccinated and Unvaccinated with 2010-
11 IIV3
Note: All estimates adjusted for sex, race (White), age (years) and age-squared, study site, work in a hospital setting or not, household size, and education (years). Among vaccinees, GMR at time 2 describes change in GMT post-
vaccination (or since Time 1); at Time 3, GMR describes change in GMT from post-vaccination to the end of season. Among unvaccinated HCP, GMR at Time 3 describes change in GMT since preseason (Time 1). GMRs were calculated 
using the log-transformed HI titers. GMTs were converted back to original GMT values. The GMR estimate was calculated by 2 to the power of mean difference estimate. The percentage with elevated tiers was estimated using generalized 
linear models with the same adjusted covariates. In addition, among vaccinees, estimates of post-vaccination elevated titers adjusted for preseason or baseline titers.  
Preseason (Time 1)
GMT >100
% (95% CI)
GMT 
(95% CI)
GMR
(95% CI)
GMT  ≥40
% (95% CI)
GMT >100
% (95% CI)
Post-Vaccination (Time 2) Post-Season (Time 3)
GMT 
(95% CI)
GMT ≥40
% (95% CI)
GMT >100
% (95% CI)
GMT 
(95% CI)
GMR
(95% CI)
GMT  ≥40
% (95% CI)
Seasonal Vaccines Influenza vaccine components
2010-11 IIV3 A/California/7/2009 (H1N1)-like virus
A/Perth/16/2009 (H3N2)-like virus
B/Brisbane/60/2008-like virus (B/Victoria)
2009-10 IIV3 A/Brisbane/59/2007 (H1N1)-like virus
A/Brisbane/10/2007 (H3N2)-like virus
B/Brisbane/60/2008-like virus (B/Victoria)
2008-09 IIV3 A/Brisbane/59/2007 (H1N1)-like virus
A/Brisbane/10/2007 (H3N2)-like virus
B/Florida/4/2006-like virus (B/Yamagata)
2007-08 IIV3 A/Solomon Islands/3/2006 (H1N1)-like virus
A/Wisconsin/67/2005 (H3N2)-like virus
B/Malaysia/2506/2004-like virus (B/Victoria)
2006-07 IIV3 A/New Caledonia/20/99 (H1N1)-like virus
A/Wisconsin/67/2005 (H3N2)-like virus
B/Malaysia/2506/2004-like virus (B/Victoria)
Supplemental Table A.  Vaccine components for seasonal 
inactivated trivalent influenza vaccines (IIV3)
Number of 
Prior 
Vaccinations 
Received 
2010-11 IIV3
Preseason 
A(H3N2) 
GMT
Post-
Vaccination 
Fold Change b
Categorical descriptors, N (%)
Study site (Oregan) 361 ( 44 ) .14 *** - .05 .05 - .17 ***
Sex (Female) 700 ( 86 ) .06 .00 .00 .05
Race (White) 650 ( 80 ) .08 ** .05 .08 * - .07
Ethnicity (Hispanic) 85 ( 10 ) - .05 - .01 .01 .02
Child (age <13) at home 248 ( 30 ) - .08 ** - .10 * .03 - .02
Physician 52 ( 6 ) .01 .07 * - .05 - .07
Work in Hospital 440 ( 54 ) - .11 *** .03 .00 .10 *
Work in Emergency Dept. 155 ( 19 ) - .09 ** - .08 * .00 .01
Chronic medical condition c 151 ( 19 ) .04 .05 - .02 .03
Continuous descriptors, Median (SD)
Age (years) 48 ( 12 )   .20 *** .12 ** - .05 - .02
Household size (0-7) 2 ( 2 ) - .11 * - .09 ** - .03 .08 *
Education (5-levels) 16 ( 2 ) .10 *** .06 - .09 * - .09 *
Self-rated health status (5-levels) 4 ( 1 ) .02 .01 - .05 - .02
Body mass index (kg/m2) 28 ( 28 ) .08 * .07 * .01 .07
Direct patient care per week (hours) 34 ( 1 ) - .09 ** - .03 .03 .02
Prior vaccinations, N (%)
2006-07 IIV3 433 ( 53 ) .78 *** .40 *** .05 - .18 ***
2007-08 IIV3 391 ( 48 ) .80 *** .38 *** .08 * - .21 ***
2008-09 IIV3 464 ( 57 ) .78 *** .41 *** .08 * - .11 **
2009-10 IIV3 589 ( 72 ) .66 *** .54 *** .20 *** - .03
Supplemental Table B. Characteristics of 816 Participants and the Spearman Correlations Between These Factors and the 
Total Number of Inactivated Trivalent Influenza Vaccinations (IIV3s) during the Prior 4 Seasons, Receipt of the 2010-11 
IIV3, Preseason Geometric Mean Titer (GMT) for A/Perth/16/2009 (H3N2), and Post-Vaccination Fold-Change in Titers  
Sample a
2009 MIV A(H1N1)pdm09 401 ( 49 ) .43 *** .40 *** .08 * - .14 ***
2010-11 IIV3 607 ( 74 ) .55 *** -- .12 *** --
Sum of Prior IIV3, Mean (SD) 3 ( 1 ) -- .55 *** .12 *** - .20 ***
c Presence of a chronic medical condition was identified by a medical visit during the prior year in the electronic medical record 
for a medical condition associated with increased risk of influenza  omplications (codes available from the authors).
* p < .05; ** p < .01; *** p < .001
a Sample (N = 816) includes health care personnel with medical and vaccination records since July, 2006 and excludes those who 
received live attenuated influenza vaccine (LAIV) in 2010-11 and/or in any season since 2006-07.
b The post-vaccination sample consists of 578 of 607 vaccinees with sera collected at both preseason and post-vaccination.
N
Sum of seasonal IIV3 
2006-07 to 2009-10
4 IIV3s 243 10 ( 9 - 11 ) 14 ( 9 - 17 ) 4 ( 1 - 5 )
3 IIV3s 176 12 ( 10 - 14 ) 19 ( 13 - 24 ) 2 ( 0 - 5 )
2 IIV3s 124 11 ( 9 - 13 ) 18 ( 11 - 24 ) 4 ( 1 - 7 )
1 IIV3s 135 12 ( 11 - 15 ) 23 ( 17 - 29 ) 8 ( 5 - 11 )
0 IIV3s 141 7 ( 6 - 8 ) 8 ( 2 - 14 ) 2 ( 0 - 5 )
Supplemental Table C.   Serum Hemagglutination Inhibition Antibody (HI) Titers 
for A/Perth/16/2009 (H3N2) at Preseason, including Estimated Geometric Mean 
Titer (GMT) and Elevated Titer ≥40 and >100, by Prior Vaccination History, 
among Healthcare Personnel  in Fall, 2010
GMT >100
% (95% CI)
Preseason (Time 1)
Note: All estimates adjusted for sex, race (White), age (years) and age squared (quadratic 
term), study site, work in a hospital setting or not, household size, and education (years) 
GMT 
(95% CI)
GMT ≥40
% (95% CI)
Subgroup Vaccination 
History N
2010-11 
Vaccinated
Aged 18-34 a Mixed 12 ( 10 - 15 ) 22 ( 16 - 27 ) 42 ( 33 - 55 ) 3.4 ( 2.8 - 4.2 ) 62 ( 53 - 71 )
Aged 35-49 a Mixed 10 ( 9 - 11 ) 14 ( 9 - 18 ) 25 ( 22 - 30 ) 2.5 ( 2.2 - 2.9 ) 44 ( 37 - 51 )
Aged 50-64 a Mixed 11 ( 10 - 12 ) 15 ( 11 - 19 ) 33 ( 28 - 38 ) 3.0 ( 2.7 - 3.4 ) 55 ( 50 - 61 )
2010-11 
Vaccinated
Sum of seasonal 
IIV3 2006-07 to 
2009-10
Aged 18-34 b
4 IIV3s 22 10 ( 7 - 16 ) 15 ( 0 - 30 ) 27 ( 17 - 43 ) 2.7 ( 1.9 - 3.7 ) 58 ( 38 - 77 )
3 IIV3s 32 11 ( 8 - 14 ) 15 ( 2 - 28 ) 26 ( 17 - 40 ) 2.4 ( 1.8 - 3.3 ) 52 ( 36 - 68 )
2 IIV3s 19 14 ( 8 - 23 ) 24 ( 7 - 41 ) 56 ( 33 - 94 ) 4.0 ( 2.3 - 6.9 ) 69 ( 48 - 90 )
1 IIV3s 23 18 ( 10 - 32 ) 34 ( 19 - 49 ) 82 ( 42 - 162 ) 4.5 ( 2.7 - 7.5 ) 73 ( 54 - 93 )
0 IIV3s 11 10 ( 5 - 20 ) 25 ( 1 - 48 ) 66 ( 21 - 206 ) 6.6 ( 2.5 - 17.9 ) 81 ( 53 - 100 )
Aged 35-49 b
4 IIV3s 73 10 ( 8 - 13 ) 14 ( 6 - 22 ) 22 ( 17 - 29 ) 2.2 ( 1.8 - 2.7 ) 40 ( 28 - 51 )
3 IIV3s 49 13 ( 10 - 17 ) 21 ( 11 - 31 ) 25 ( 19 - 34 ) 2.0 ( 1.6 - 2.4 ) 48 ( 34 - 61 )
2 IIV3s 31 8 ( 6 - 11 ) 11 ( 0 - 23 ) 27 ( 17 - 43 ) 3.4 ( 2.4 - 4.9 ) 43 ( 26 - 60 )
1 IIV3s 30 10 ( 7 - 13 ) 16 ( 3 - 29 ) 34 ( 24 - 49 ) 3.5 ( 2.3 - 5.2 ) 55 ( 38 - 73 )
0 IIV3s 8 5 ( 4 - 7 ) 0 ( 0 - 22 ) 20 ( 5 - 84 ) 3.7 ( 0.8 - 16.0 ) 31 ( 0 - 63 )
Aged 50-64 b
Supplemental Table D.   Serum Hemagglutination Inhibition Antibody (HI) Titers at Preseason, Post-Vaccination, and End-of-
Season for A/Perth/16/2009 (H3N2) by Influenza Vaccination History, including Estimated Geometric Mean Titer (GMT), 
Elevated Titer ≥40, and Geometric Mean Fold Change Ratios (GMRs), among Healthcare Personnel Vaccinated and 
Unvaccinated with 2010-11 Inactivated Influenza Trivalent Vaccine (IIV3) Stratified by Age Group
Preseason (Time 1) Post-Vaccination (Time 2)
GMT 
(95% CI)
GMT ≥40
% (95% CI)
GMT 
(95% CI)
GMR
(95% CI)
GMT  ≥40
% (95% CI)
4 IIV3s 132 10 ( 8 - 11 ) 12 ( 6 - 19 ) 23 ( 19 - 28 ) 2.2 ( 1.8 - 2.7 ) 42 ( 34 - 50 )
3 IIV3s 72 13 ( 10 - 16 ) 20 ( 12 - 29 ) 41 ( 32 - 54 ) 2.0 ( 1.6 - 2.4 ) 67 ( 56 - 79 )
2 IIV3s 35 10 ( 7 - 13 ) 20 ( 7 - 32 ) 30 ( 19 - 49 ) 3.2 ( 2.2 - 4.7 ) 54 ( 38 - 70 )
1 IIV3s 33 14 ( 9 - 22 ) 27 ( 14 - 39 ) 69 ( 40 - 118 ) 4.9 ( 3.1 - 7.9 ) 76 ( 60 - 92 )
0 IIV3s 8 9 ( 3 - 31 ) 9 ( 0 - 31 ) 87 ( 27 - 287 ) 9.5 ( 1.9 - 46.9 ) 67 ( 36 - 98 )
Note: Given the small number of participants in the stratified models, only age (years) and study site were included in the multivariable 
models; models including all covariates offered similar result. The models were calculated using the log-transformed HI titers. GMTs 
were converted back to original GMT values. The GMR estimate was calculated by 2 to the power of mean difference estimate. GMT 
>100 was not calculated given the small number of participants with highly elevated titers stratified by age. 
b Statistically significant interactions between number of prior vaccinations and GMR were noted for HCP aged 18-34 years (F[4,100] = 
2.88, p = .026, partial η2 = .10), HCP aged 35-49 years (F[4,184] = 2.47, p = .03, partial η2 = .06), and HCP aged 50-64 years (F[4,273] 
= 6.13, p < .0005, partial η2 = .08).
a A statistically significant interaction between age and GMR was noted (F[2, 569] = 3.41, p = .03, partial η2 = .01). Statistically 
significant parameters for age and age-squared were also noted in the models (p's < .0005). Taken together, this prompted secondary 
analyses to examine results stratified by age group. Each row includes HCP within that age group and includes a mixture of prior 
vaccination exposures in that strata. Due to the reduced number of participants in each strata, we did not estimate the percentage with 
titers >100. 
Sum of IIV3 
2006-07 to 
2009-10 N
4 IIV3s 200 2.5 ( 2.2 - 2.8 ) 37 ( 30 - 43 ) 5 ( 1 - 9 )
3 IIV3s 125 2.9 ( 2.5 - 3.4 ) 43 ( 35 - 51 ) 4 ( 0 - 9 )
2 IIV3s 73 3.8 ( 2.9 - 4.8 ) 47 ( 37 - 57 ) 12 ( 5 - 18 )
1 IIV3s 6 4.9 ( 3.6 - 6.7 ) 57 ( 47 - 68 ) 22 ( 15 - 29 )
Note: These results exclude participants with preseason GMT of ≥40. Due to 
the reduced sample in this stratified analysis, participants with zero prior 
vaccinations were excluded. All estimates adjusted for sex, race (White), age 
(years) and age-squared, study site, work in a hospital setting or not, 
household size, and education (years). Post-vaccination GMR describes 
change in GMT from preseason to post-vaccination. GMRs were calculated 
using the log-transformed HI titers. GMTs were converted back to original 
GMT values. The GMR estimate was calculated by 2 to the power of mean 
difference estimate. The percentages of HCP with elevated tiers were 
estimated using generalized linear models with the same adjusted covariates. 
In addition, post-vaccinated elevated titers adjust for preseason or baseline 
titers. 
Supplemental Table E.  Serum Hemagglutination Inhibition Antibody 
(HI) Titers for A/Perth/16/2009 (H3N2) Post-Vaccination by Number of 
Inactivated Influenza Vaccinations (IIV3s) during the Prior Four 
Seasons, among 404 Participants with Preseason GMT of <40, including 
Geometric Mean Fold Change Ratios (GMRs) and the Percentage who 
Achieved Elevated Titers of ≥40 and >100 
Post-Vaccination (Time)
GMR
(95% CI)
GMT  ≥40
% (95% CI)
GMT >100
% (95% CI)
